Upcoming Pharm-Olam Webinar Helps Sponsors Manage Rescue Study Transitions

HOUSTON–(BUSINESS WIRE)–Pharm-Olam,
a global, midsized CRO offering full-service clinical development
solutions for oncology-hematology, infectious diseases and vaccines and
rare diseases, will be sharing key strategies for pharmaceutical
companies needing to transition studies to a different CRO in a free
webinar on June 18.

The webinar, “Rescuing Your Study – A Sponsor’s Playbook,” will present
insights from more than 100 rescue studies that Pharm-Olam has saved.
Presenters are Shannon
Hambridge, vice president of global project management, and Sarah
Liddiard, senior director of global project management.

“Migrating a study to a new CRO can be time-consuming and fraught with
unexpected difficulties,” said Liddiard. “We will share some best
practices to help sponsors successfully navigate pain points or avoid
them altogether.”

During the webinar, speakers will cover the following topics:

• Tips and advice for planning your study transition
• What to provide to CROs bidding to save your trial
• How long to allow for full transition
• How to keep outgoing and incoming CROs informed
• How to manage and support outgoing and incoming CROs
• Common pain points
• Tips and considerations for contractual requirements

“When a sponsor is faced with a study that needs rescuing, it is often
because of quality, recruitment, study management or financial
management problems,” said Hambridge. “Too often, these transfers are
marked by confusion and stress. By leveraging the expertise we’ve gained
by rescuing numerous studies, we will give sponsors valuable information
to proactively manage and streamline the transition of current and
future rescue studies.”

Registration for the webinar is available here.

About Pharm-Olam
Pharm-Olam is Helping Create a Healthier
World as a global, midsized CRO that offers flexible, innovative, and
highly personalized clinical solutions to pharmaceutical, biotechnology,
and life science companies. Our team is well-known for producing quality
results with reduced risk, costs, and timelines in challenging
international trials. Learn more about our full-service solutions, data
protection services, and expertise in oncology, infectious diseases and
vaccines, rare and orphan diseases, pediatrics, and general medicine at pharm-olam.com.

Contacts

Jane Byram
SCORR Marketing
(512) 626-2758
[email protected]